Natural health product · NPN 80133959
Bifizen
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed August 30, 2024.
- Natural Product Number (NPN)
- 80133959
- Licence holder
- 1180056 B.C. Ltd.
- Dosage form
- Capsule
- Route
- Oral
- Licensing route
- General (non-traditional)
- First licensed
- August 30, 2024
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Lacticaseibacillus Rhamnosus | 1 billion cfu | LR06 (DSM 21981) |
| Bifidobacterium longum subsp. longum | 1 billion cfu | BL-04 |
| Bifidobacterium longum subsp. longum | 1 billion cfu | DSM 23233 |
| Bifidobacterium longum subsp. longum | 1 billion cfu | Bifidobacterium longum subsp. longum - Whole cell |
| Limosilactobacillus Fermentum | 1 billion cfu | LF16 (DSM 26956) |
| Lactiplantibacillus plantarum | 1 billion cfu | Lactiplantibacillus Plantarum - Whole Cell |
| Lactiplantibacillus plantarum | 1 billion cfu | LP01 (LMG P-21021) |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Source of Probiotics.
Non-medicinal ingredients
Maltodextrin; Magnesium stearate; Silicon dioxide; Sucrose; Hypromellose